ORA Research News - Monday, July 22, 2019
Pew-Stewart Cancer Research Opportunity
The Pew-Stewart Scholars Program for Cancer Research supports assistant professors of outstanding
promise in science relevant to the advancement of a cure for cancer. The award provides $300,000 in
flexible support—$75,000 per year for a four-year period. In line with the Stewart Trust's mission to invest
in innovative, cutting-edge, basic cancer research that may accelerate and advance progress toward a
cure for cancer, applications are invited from one nominee at OUHSC conducting cancer research.
Deadline for pre-proposal July 31st, 2019.Eligibility:
- Candidates must have been awarded a doctorate in biomedical sciences or medicine.
- As of Oct. 10, 2019, nominees must hold a full-time appointment at the rank of assistant professor.
- Appointments such as research assistant professor, adjunct assistant professor, assistant
professor research track, visiting professor, or instructor are NOT eligible.
- On June 14, 2019, candidates must have been in such an appointment for less than three years (not
appointed before June 14, 2016). Time spent in clinical internships, residencies, in work toward board
certification, or on parental leave does not count as part of this three-year limit. Candidates who took
parental leave should contact Pew's program office to ensure that application reviewers are aware of
Pre-proposal Application Details:
- Interested applicants should submit all pre-proposal materials, including:
- Research project summary – 500 word limit
- Specific Aims page – 1 page limit (11 pt font or larger)
- Curriculum vitae
- Letter of support from the Departmental Chair and/or Section Chief
- Submit all materials as a single PDF file to:
Stevie Warner, Sponsored Programs and Initiatives Manager
SCC Education and Training Core
- The internal selection committee will evaluate and discuss the pre-proposals and select the most suitable applicant to nominate for the Pew-Stewart Scholars Program for Cancer Research.
Should you have questions, please contact Stevie Warner (Stevie-Warner@ouhsc.edu of 405/271-2537)
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Pew-Stewart Pre-Proposal for Cancer Research.docx?ver=2019-07-22-074412-740
Grants and Contracts Accounting Newsletter for July 19, 2019 s attached.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/GCA News July 2019.pdf?ver=2019-07-22-074636-413
Research Protection: Please read the attached “Dear Colleague Letter” on the topic of research protection.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Research Protection (nsf19200) _ NSF - National Science Foundation.pdf?ver=2019-07-22-075109-530
OSCTR TPIR Trainee Program
Seeking applicants for the sixth year of the research training program Translating Practice into
Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic
Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal
of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to
translate their clinical observations and ideas for improving practice into practical and feasible research
projects. Attached is a detailed description and application due September 3, 2019.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/TPIR Flyer 2019.pdf?ver=2019-07-22-080259-980
PRESBYTERIAN HEALTH FOUNDATION GRANTS – REQUEST FOR APPLICATIONS – CYCLE II
Bridge Grant Program – DUE DATE AUGUST 16, 2019 (REVISED GUIDELINES)
The primary objective of the PHF Bridge Grant program is to provide funding to enhance OUHSC faculty
competitiveness for extramural funding. OUHSC Principal Investigators who have submitted an extramural
application that was scored but not funded within the past 18 months and is requesting over $750,000 in total
direct costs and over $200,000 in total facilities and administration (F&A) costs and received a review that
ranks applications and provides critiques are eligible. This program can provide funding for up to $75,000
for one year. Guidelines and Application Form is attached or can be found at:
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Bridge Grant Guidelines - August 16 2019.docx?ver=2019-07-16-080651-860
Interested in becoming an IRB Member?
The OUHSC Institutional Review Board (IRB) currently has openings for new IRB members. The IRB reviews
applications and reports for human research projects to ensure that the rights and welfare of human participants
are protected and that risk of harm is minimized.
If you are interested in medical or social science research and would like to be involved with protecting the rights,
safety and welfare of individuals who volunteer to participate in research, IRB membership may be for you.
Current members have expressed that of all the committee’s they have participated in, the IRB has been the
most rewarding. Members enjoy an increased understanding of research and exposure to cutting edge issues
and current controversies in medical diagnostics and treatments. In addition, valuable collaboration may result
from working closely with board members from a variety of disciplines.
If you are interested in learning more about IRB membership, please contact the HRPP Office at 405-271-2045
or email to email@example.com.
The Diabetes CoBRE Program at OUHSC intends to support pilot projects. The goal is to provide seed
funds to support projects that have the potential to receive NIH funding in the future. Any investigator working in
the state of Oklahoma who meets the requirements defined below, and who has a project related to diabetes or
diabetic complications, is welcome to apply. The application deadline is 5pm, August 16, 2019.
Funding starts by October 1, 2019. See the attached document and go to:
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Pilot Projects in Diabetes CoBRE flyer 2019.pdf?ver=2019-07-22-082134-707
Reminders of NIH Policies on Other Support and Policies Related to Financial Conflicts of Interest
and Foreign Components
The Society of Research Administration is a great resource for grant management and processes training.
We encourage departments to support their employees that are involved with the management of a grant to attend
these meetings. There are annual meetings and other meetings that cover more specific topics. The meetings are
a great resource for grant specific knowledge and networking with people in similar roles.
The University has contracted with a new vendor for biomedical waste transport and treatment. Capital
Waste Solutions, LLC has been awarded the new contract that becomes effective August 1, 2019. During the
next 30 days, Stericycle will contact each department to schedule final pickup services and also to retrieve their
containers and bins. Also during this 30 day transition, it is important that you make arrangements with the new
contracted vendor; Capital Waste Solutions, LLC to set up your departmental account and billing information, and
arrange a new pickup schedule. Please reference OU RFP# R-20009-20. Information for the account representative
and contact information is below and will also be listed on the Purchasing website. If you have questions about this
transition, you can email firstname.lastname@example.org and identify your department and campus and someone will
Capital Waste Solutions, LLC
Cell phone: 918-500-0369
Office phone: 918-477-0100
Purchasing website link: www.ou.edu/purchasing
IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to support collaborative
research activities between OUHSC researchers and OU-Norman researchers in the area of biomedical engineering
Deadline August 1, 2019 – please see guidelines and face page attached
Biosafety Level 3 Containment Laboratory (BSL-3) – Following an initial lab shutdown for replacement of the
flooring, multiple problems requiring intervention were discovered leading to a lengthy renovation. The renovation and
remediation of the laboratory is now finished, and as of July 1, 2019 the laboratory is back open for use by OUHSC
investigators. If you have a need to work in the BSL-3 containment laboratory or for additional information, please
contact the Facility Manager, Arto Baghdayan (email@example.com; 271-3393 or ex.30071).
The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational
Resources (OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP) Grants Program
and its Community Engaged Research Exploratory Awards.
Oklahoma Shared Clinical and Translational Resources Clinical and Translational Research Pilot
The purpose of the program is to provide funding for collaborative and/or multi-disciplinary clinical and translational
pilot projects between investigators of the OSCTR member institutions. The program seeks to support proposals designed
to generate preliminary data that will result in improved health and/or healthcare for citizens of Oklahoma and other IDeA
states and enhance the competitiveness of the investigators for future extramural funding. The program also seeks to fund
innovative concepts, approaches, and methodologies that bring fresh new ideas to solving the health issues of those living
in Oklahoma and collaborating IDeA states. Projects that focus on the medically underserved and on health concerns
prevalent within Oklahoma and our OSCTR partners will be a priority. Only projects which meet the NIH definition of clinical
and/or translational research will be accepted.
Approved CTRP grants will be funded for a period starting January 1, 2020 contingent on NIH approval of just in time (JIT)
information. All funds are required to be expended by December 31, 2020.
The forms, instructions, and submission link can be found at: http://osctr.ouhsc.edu/pilots2019
Deadlines for submission: Pilot Proposal – Friday, August 9, 2019 at 5:00 PM CDT
Oklahoma Shared Clinical and Translational Resources Community-Engaged Research Exploratory
This program is intended to support community engagement to develop funded research partnerships. Funds can be
used for research development activities, including convening partners, working with individuals pursuing related work,
and conducting needs assessments in community settings. The funds cannot be used to support actual human-subjects
research protocols, which can be funded under other OSCTR pilot research programs and/or external funding.
The application should consist of a 2-page letter from the main applicant (which can be either a community agency or an
academic researcher) describing the collaboration, the contributions that the proposed work will make to a successful
research partnership, and a line item budget. Budget requests are expected to be $5,000-$10,000 with budgets that
permit the expenditure of the entire award by June 30, 2020. A separate letter of support from either the academic or
community partner indicating their agreement with the proposed activities should also be included. Proposals will be
evaluated on a rolling basis beginning July 1, 2019. Please submit proposals by email to firstname.lastname@example.org.
Interested applicants can discuss their proposal, eligibility, allowable budget items, and available funding by contacting
the OSCTR staff at email@example.com or call 405-271-3480.
Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 16th Annual Harold Hamm
Diabetes Center Research Symposium. This event will be held on Friday, November 15, 2019 at the Samis
Education Center at Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced later this summer.
Additional details will be posted on http://haroldhamm.org/ Questions? Please email
Requirement for ORCID iDs for Individuals Supported by Research Training, Fellowship, Research Education, and
Career Development Awards Beginning in FY 2020 (NOT-OD-19-109)
Reminders of NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest and
Foreign Components (NOT-OD-19-114)
Notice of New NIH-Designated Data Repository: NHGRIs Genomic Data Science Analysis, Visualization, and
Informatics Lab-space (AnVIL) (NOT-HG-19-024)
Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for RFA-OD-19-021 "Maximizing the
Scientific Value of Existing Biospecimen Collections" and RFA-OD-19-022 "Secondary Analyses of Existing Datasets
of Tobacco Use and Health" (NOT-OD-19-115)
Request for Information (RFI): Guidance on Current Education Curricula for Health Care Professionals Regarding Pain
and Opioid Misuse and Use Disorder (NOT-DA-19-054)
Notice of Change to RFA-AG-20-024 "Science of Behavior Change (SOBC) Resource and Coordinating Center
(U24 Clinical Trial Not Allowed" (NOT-AG-19-027)
Notice of Change to NOT-AG-19-017 "Request for Information (RFI): Inviting comments and suggestions for the
development of the NIA Longitudinal Rat Resource to study neural and behavioral trajectories of successful cognitive
Notice of Correction RFA-DA-20-008, "Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and
Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)" (NOT-DA-19-058)
Notice of Clarification to Institutional Eligibility and Correction to the Cap for Training Related Expenses in PAR-19-299
"Bridges to the Baccalaureate Research Training Program (T34)" (NOT-GM-19-046)
Notice of Clarification of Institutional and Program Director/Principal Investigator Eligibility for PAR-19-037 Initiative for
Maximizing Student Development (IMSD) (T32) (NOT-GM-19-047)
Notice of Change to HEAL Initiative: Announcement of Collaboration Opportunities for Developing Drugs and Human
Cell-Based Testing Platforms for Pain, Addiction and Overdose (NOT-TR-19-018) (NOT-TR-19-025)
Notice of Change to NOT-TR-19-014: Notice of Change to PAR-18-940 Clinical and Translational Science Award
(U54 Clinical Trial Optional) (NOT-TR-19-026)
Notice of Intent to Publish a Funding Opportunity Announcement for HIV-associated Non-Communicable Diseases
Research at Low- and Middle-Income Country Institutions (NOT-TW-19-005)
John E. Fogarty International Center
HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2020-1) Now Available
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol,
and Tobacco Use Disorders (R01, R21, R03) (NOT-DA-19-037)
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21)
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction (NOT-DA-19-048)
Notice of Special Interest (NOSI): Biosensors to Detect Exacerbations of Cardiopulmonary Disease
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) (PAR-19-311) - Deadline October 16, 2019
NIA Program Project Applications (P01 Clinical Trial Optional) (PAR-19-314) – Deadline September 25, 2019
Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical
Trial Optional) (PAR-19-315) – Deadline September 4, 2019 and February 14, 2020
Specialized Alcohol Research Centers (P50 Clinical trial Optional) (RFA-AA-20-001) – Deadline November 14, 2019
Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) (RFA-AA-20-002) – Deadline November 14, 2019
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 -
Clinical Trials Not Allowed) (RFA-DA-20-006) – Deadline November 14, 2019
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 –
Clinical Trials Not Allowed) (RFA-DA-20-007) – Deadline November 14, 2019
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
(RFA-DA-20-023) – Deadline November 12, 2019
Population Dynamics Centers Research Infrastructure Program FY 2020 (P2C Clinical Trial Not Allowed)
(RFA-HD-20-015) - Deadline August 30, 2019
Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related
dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) (RFA-NS-20-004)
Deadline October 9, 2019
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research
(R21 Clinical Trial Not Allowed) (RFA-OD-19-021) – Deadline October 8, 2019 and August 7, 2020
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
(RFA-OD-19-022) – Deadline October 8, 2019 and July 20, 2020
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases
(R03 Clinical Trial Not Allowed) (RFA-RM-19-011) – Deadline October 28, 2019